Fact Check: In her resignation letter, Terrell warned colleagues that she felt Tulane’s leaders 'have chosen to abandon the principles of knowledge, education, and the greater good in pursuit of their own narrow agenda.'

Fact Check: In her resignation letter, Terrell warned colleagues that she felt Tulane’s leaders 'have chosen to abandon the principles of knowledge, education, and the greater good in pursuit of their own narrow agenda.'

Published June 14, 2025
VERDICT
True

# Fact Check: "In her resignation letter, Terrell warned colleagues that she felt Tulane’s leaders 'have chosen to abandon the principles of knowledge...

Fact Check: "In her resignation letter, Terrell warned colleagues that she felt Tulane’s leaders 'have chosen to abandon the principles of knowledge, education, and the greater good in pursuit of their own narrow agenda.'"

What We Know

Kimberly Terrell, a researcher at Tulane University, recently resigned, citing concerns over censorship from university leadership regarding her work on environmental issues and racial disparities in Louisiana. In her resignation letter, she explicitly stated that she felt Tulane's leaders "have chosen to abandon the principles of knowledge, education, and the greater good in pursuit of their own narrow agenda" (AP News, Inside Higher Ed). This resignation was prompted by what she described as a "gag order" imposed on her and her clinic, which she claimed hindered her ability to speak publicly about her research (NOLA, WDSU).

Analysis

The claim that Terrell warned her colleagues about Tulane's leadership abandoning core educational principles is directly supported by her resignation letter, which has been reported by multiple reputable sources. The Associated Press, Louisiana Illuminator, and Inside Higher Ed all quote her resignation letter verbatim, confirming the accuracy of the statement (AP News, Louisiana Illuminator, Inside Higher Ed).

The context surrounding her resignation adds weight to her claims. Terrell's work focused on the health impacts of the petrochemical industry in Louisiana, an area of significant concern for local communities, particularly those labeled as "Cancer Alley" due to high rates of pollution and associated health issues (AP News). The university's leadership reportedly faced pressure from state officials and donors, which Terrell argued compromised academic freedom and integrity (NOLA, WDSU).

The sources reporting on this incident are credible, with the Associated Press being a well-established news organization known for its journalistic standards. The Louisiana Illuminator and Inside Higher Ed also have reputations for covering educational and environmental issues thoroughly.

Conclusion

The claim that Terrell warned her colleagues about Tulane's leadership abandoning the principles of knowledge, education, and the greater good is True. This assertion is substantiated by her resignation letter and corroborated by multiple reliable news sources, which report her exact words and the context in which they were made.

Sources

  1. Texas Prepaid Higher Education Tuition Board ... Link
  2. Tulane scientist resigns citing university censorship of pollution and racial disparity research Link
  3. Tulane scientist resigns, citing 'gag order' on environmental Link
  4. Tulane Environmentalist Resigns Amid Research “Gag Order” Link
  5. Tulane environmental researcher resigns, citing 'gag order' Link
  6. Tulane scientist resigns citing university censorship Link
  7. Tulane scientist resigns citing university censorship of ... Link
  8. 10 songs to celebrate the life and legacy of the Beach Boys ... Link

Have a claim you want to verify? It's 100% Free!

Our AI-powered fact-checker analyzes claims against thousands of reliable sources and provides evidence-based verdicts in seconds. Completely free with no registration required.

💡 Try:
"Coffee helps you live longer"
100% Free
No Registration
Instant Results

Comments

Leave a comment

Loading comments...

More Fact Checks to Explore

Discover similar claims and stay informed with these related fact-checks

Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: In her resignation letter, Terrell warned colleagues that she felt Tulane’s leaders 'have chosen to abandon the principles of knowledge, education, and the greater good in pursuit of their own narrow agenda.' | TruthOrFake Blog